Eli Lilly Reports Earnings on Oct. 29. Here's Why the Retatrutide Story Matters More Than the Quarter.

Eli Lilly's next big growth driver could be bigger than Zepbound.

CryptoAlerta — análise de criptomoedas e mercado em tempo real